Aceto (NASDAQ:ACET)

GeoProfile
Overview
GeoSpecial
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

Do you represent this company?

Learn how we can help increase your exposure to investors.

Friday, May 4, 2012, 9:19AM
GeoSpecial Aceto (NASDAQ:ACET) reports strong third quarter 2012 results. Third quarter 2012 EPS of $0.20 vs $0.14 in prior year period.

Wednesday, April 11, 2012, 8:50AM
GeoSpecial Aceto (NASDAQ:ACET) announced that Rising Pharmaceuticals, its finished dosage form generic subsidiary, has launched Carisoprodol, Aspirin and Codeine phosphate Tablets USP, an approved generic version of Meda Pharmaceutical's Soma Compound with Aspirin and Codeine Tablets, and Dexamethasone Elixir USP, an approved generic version of Merck & Company, Inc. (NYSE:MRK) Decadron Elixir.

Friday, March 9, 2012, 11:28AM
GeoSpecial Aceto (NASDAQ:ACET) hits new 52 week high.

Thursday, February 23, 2012, 4:19PM
Seeking Alpha article on GeoSpecial Aceto (NASDAQ:ACET)

Friday, February 10, 2012, 9:16AM
GeoSpecial Aceto (NASDAQ:ACET) reports strong second quarter 2012 results. Reports EPS of $0.17 vs $0.08 in prior year quarter.

Friday, November 4, 2011, 9:01AM
GeoSpecial Aceto (NASDAQ:ACET) reports strong first quarter 2012 results. Reports EPS of $0.13 vs. $0.11 in prior year and beats analyst estimates of $0.07

Wednesday, December 15, 2010, 2:23PM
GeoSpecial Aceto (NASDAQ:ACET) to Acquire Certain Assets of Rising Pharmaceuticals, Inc.

Thursday, October 7, 2010, 12:25PM
GeoSpecial Aceto (NASDAQ:ACET) attains new 52-wk high.

Friday, September 10, 2010, 9:20AM
GeoSpecial Aceto (NASDAQ:ACET) Announces All-Time Record Quarterly Sales of $105.8 Million for Fiscal 2010 4th Quarter.

Tuesday, May 11, 2010, 2:25PM
Aceto (NASDAQ:ACET) coded as a GeoSpecial @ $6.53. Focus is on P/E ratio valuation gap.